RecruitingNot ApplicableNCT06565143
Effect of Transcranial Alternating Current Stimulation(tACS) for Early Alzheimer's Disease
Sponsor
Anhui Medical University
Enrollment
40 participants
Start Date
Mar 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
To investigate the clinical effect neural mechanism of transcranial alternating current stimulation in early Alzheimer's disease
Eligibility
Min Age: 50 YearsMax Age: 85 Years
Inclusion Criteria5
- Subject diagnosed with early Alzheimer's disease or related diseases according to NIA-AA criteria.
- Subjects must have a MMSE score between 10 and 27,indicating mild cognitive impairment or dementia.
- CDR score ≤ 2.
- Subject under treatment by IAChE for at least 3 months.
- psychotropic treatments are tolerated if they were administered and unchanged for at least 3 months.
Exclusion Criteria8
- CDR \> 2
- Any history or clinical signs of other severe psychiatric illnesses (like major depression,psychosis or obsessive compulsive disorder).
- History of head injury,stroke,or other neurologic disease.
- Organic brain defects on T1 or T2 images.
- History of seizures or unexplained loss of consciousness.
- Implanted pacemaker,medication pump,vagal stimulator,deep brain stimulator.
- Family history of medication refractory epilepsy.
- History of substance abuse within the last 6 months.
Interventions
DEVICETranscranial alternating current stimulation
Transcranial alternating current stimulation (tACS) is a non-invasive brain stimulation tool that alters cortical excitability and activity via application of weak alternating currents.
DEVICESham transcranial alternating current stimulation
In the sham condition, tACS was delivered only during the ramp-up and ramp-down periods (30s); no current was delivered during the 30-minute intervention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06565143
Related Trials
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
NCT0703349470 locations
A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease
NCT072524401 location
Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
NCT070878731 location
High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease
NCT045997641 location
Efficacy of Hi-tACS for Schizophrenia Negative Symptoms
NCT068887261 location